FEATURED VIDEOS

• Balancing Quick Results And Careful Planning

  In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists answer an audience question about how to navigate fast-paced development thoughtfully, which is especially critical for startups operating on a lean budget.

• Preparing A Gap Analysis

  Ahead of a tech transfer, conducting a gap analysis or gap assessment is critical to ensure a smooth transfer of methods. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, Stephan Krause, Ph.D., and William Janssen, Ph.D., discuss the importance of performing gap assessments.

• Controlling Analyst Bias

  Panelist Cheryl Cox responds to an audience question about controlling analyst bias and gating for flow cytometry.

• Keys To A Successful Tech Transfer

  Transferring analytical methods can be challenging, especially with manual processes, which can have more nuance to their conduct outside of an SOP. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists discuss the best way to approach the transfer of analytical methods.

• Phase-Appropriate Risk Management Strategies

  Panelist Cheryl Cox addresses an audience question about risk management strategy and assessing product safety throughout development.

• Method Qualification Versus Method Validation

  Stephan Krause, Ph.D., responds to an audience question about the difference between method qualification and method validation in terms of activities.

• Considerations For Characterization Assays And Release Testing

  Panelist Stephan Krause, Ph.D., from Bristol Meyers Squibb shares his thoughts on characterization assays and release testing, noting the unique patient-specific quality attributes inherent in autologous products.

• Developing Safety And Potency Assays

  When it comes to potency assays, you should develop and validate them as early as possible. In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists weigh in on key considerations for potency assay development.

• Defining A Good Method Development Strategy

  In this segment from the Bioprocess Online Live! Event Designing Transferable Analytical Methods, our panelists explain the importance of phase-appropriate analytical development and define what a good analytical method development strategy looks like. They agree that it’s important to address any deficiencies early in development to avoid problems in later-stage tech transfers.

• Multicolor Flow Cytometry Panel Design

  Watch a series of videos on multicolor flow cytometry panel design to gain a comprehensive understanding of the fundamentals of panel design as well as various strategies to streamline panel design.

• Accelerate Cross Site Collaboration With Simple Assay Transfer

  Collaboration across sites is critical in the journey from development to manufacturing. Watch to discover how to accelerate cross-site collaboration with simple assay transfer.

• BD FACSDuet™ Premium: Sample Preparation System

  Watch to learn how you can empower your laboratory team and fully automate a wide range of workflows with a revolutionary sample preparation system.

• Ask The Expert: 21 CFR Part 11 Compliance

  Hear from a 21 CFR Part 11 expert with nearly 20 years of experience supporting pharmaceutical, diagnostic, and medical device companies with implementing solutions and systems to ensure compliance.

• Dissecting Cellular Composition Using Single-Cell Multiomics

  Hear from Dr. Fabio Luciani, Professor and Senior Researcher in Systems Immunology at the School of Medical Sciences and the Kirby Institute at UNSW Sydney about his recent research.

• Standardization Of Flow Cytometry In Cell And Gene Therapy

  Watch to learn about solutions to address challenges in standardizing flow cytometry and cell analysis solutions that support drug development at every stage.

• Cell Therapy - Pushing The Limit

  Tremendous advances in the development of cell-based therapies now offer the ability to treat patients who previously had no hope. Watch to learn about the possibilities for cell-based therapies.